Literature DB >> 2531111

Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals.

M M Barbey1, L M Fels, M Soose, K Poelstra, W Gwinner, W Bakker, H Stolte.   

Abstract

The early nephrotoxic effect of the antitumor drug adriamycin (ADR) is suggested to be related to the generation of oxygen free radicals. Therefore the O2-dependence and the influence of free radical scavengers were studied in the model of the isolated perfused single glomerulus of Myxine glutinosa and by histochemical demonstration of the glomerular ATP-ase. In Myxine, the glomerular ATP-ase activity was decreased after injection of ADR (5 mg/kg, i.v.). Both ADR-treated Myxine and controls were exposed for 48 h to an artificial atmosphere of 20% O2/80% N2 or 80% O2/20% N2, respectively. After 10 days a significant decrease of the hydraulic conductivity (k) was measured in the experimental group exposed to 80% O2 (k-values expressed as nl/s.mm Hg.mm2: controls (7): 0.059 +/- 0.017; ADR (7): 0.033 +/- 0.026). The reduction of k following the administration of ADR (20 mg/kg) could be prevented by the sulphydryl donor N-acetylcysteine (NAC). The sieving coefficient for albumin (phi) was significantly increased in ADR-treated animals, showing no O2-dependence (phi x 10(-2): controls (7) 1.3 +/- 0.2; ADR 20% O2 (8): 8.1 +/- 9.6; ADR 80% O2 (7): 6.9 +/- 6.7). phi was not affected by NAC. The lipid peroxide levels in liver, kidney and heart of Myxine increased after the administration of ADR, peaking by day 2 to 5. The circulation disorders of ADR-treated Myxine were not due to an accumulation of the drug in the heart, but rather to a lack of the intracellular antioxidant glutathione. It is concluded that the early nephrotoxic effect of ADR, as reflected by a decreased glomerular ATP-ase activity, is mediated by free radical formation. Oxidative stress on membrane compounds seems to reduce the water permeability of the glomerular barrier, while the ADR-induced sieving defect may be due to oxygen independent pathological mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531111     DOI: 10.3109/10715768909087942

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  6 in total

1.  Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.

Authors:  Andrea B Kramer; Mirjan M van Timmeren; Theo A Schuurs; Vishal S Vaidya; Joseph V Bonventre; Harry van Goor; Gerjan Navis
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-18

2.  Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.

Authors:  Alper Sonmez; Mahmut Ilker Yilmaz; Ahmet Korkmaz; Turgut Topal; Kayser Caglar; Ayper Kaya; Tayfun Eyileten; Mujdat Yenicesu; Yusuf Oguz; Seref Basal; Osman Metin Ipcioglu; Abdulgaffar Vural
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

3.  Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine.

Authors:  M M al-Harbi; N M al-Gharably; O A al-Shabanah; A M al-Bekairi; A M Osman; H N Tawfik
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury.

Authors:  Jun-Jae Chung; Leonard Goldstein; Ying-Jiun J Chen; Jiyeon Lee; Joshua D Webster; Merone Roose-Girma; Sharad C Paudyal; Zora Modrusan; Anwesha Dey; Andrey S Shaw
Journal:  J Am Soc Nephrol       Date:  2020-07-10       Impact factor: 10.121

5.  Fibronectin turnover in human mesangial cell cultures as affected by adriamycin.

Authors:  M Soose; S Wenzel; H Stolte
Journal:  Cell Biol Toxicol       Date:  1993 Apr-Jun       Impact factor: 6.691

6.  Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Cláudia Martins Carneiro; Dirceu de Sousa Melo; Karine Beatriz Costa; Fábio Lourenço Tadeu Guimarães; Etel Rocha-Vieira; Érica Leandro Marciano Vieira; Ana Cristina Simões e Silva
Journal:  Mediators Inflamm       Date:  2015-05-07       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.